adcs covid-19 lipid nanoparticles protac pegylation adc drugs semaglutide drug delivery antibody-drug conjugates type 2 diabetes cancer covid-19 vaccine breast cancer protacs adc liposomes immunotherapy antibody drug conjugates click chemistry bispecific antibodies adc drug type 1 diabetes cancer immunotherapy remdesivir mrna technology pdcs hydrogels peptide drugs 3d bioprinting diabetes cancer therapy metformin favipiravir pegylated peg derivatives drug enhertu targeted protein degradation lnps trodelvy hiv tnbc mrna vaccine prostate cancer zynlonta covid-19 vaccines gene therapy triple-negative breast cancer antibody-drug conjugate solid tumors peg pharmaceutical weight loss mabs sglt2 inhibitors donanemab glp-1 receptor agonists peptide drug conjugates wegovy insulin isac targeted therapy nanomedicine antiviral drug vitamin d protein influenza baloxavir marboxil peg lipids frα target cervical cancer targeted drugs geographic atrophy lecanemab hypoglycemic trop-2 monoclonal antibodies claudin18.2 nsclc adc targets trop2 her2 kadcyla ds-8201 degrader-antibody conjugates protac technology car-t cells molecular glues bystander effect smdc crispr antibody–drug conjugates kimmtrak triple negative breast cancer covid-19 drugs pdc paxlovid diabetes treatment nanoparticles tirzepatide adc linker cancer treatment peg linkers stem cell therapy tivdak covid-19 mrna vaccines vaccine delivery aids covid-19 variant mrna vaccines chemotherapy keytruda tissue factor nucleic acid liraglutide hepatitis b cancer cells sacituzumab govitecan huateng pharma dementia oseltamivir malignant tumor antibody-drug conjugations antihypertensive drugs proteolysis targeting chimera melanoma flu larotrectinib intermediates glp-1 fda development carfilzomib xofluza drug carrier anticancer therapeutics cyclic peptides aocs oligonucleotide aducanumab alzheimer's disease claudin 6 nbe-002 mk-2140 ror1 adcs anti-tumor drugs new targets dspe plant-derived cholesterol non-cleavable linker cleavable linker tpgb5t4 trophoblast glycoprotein neutropenia peg‐rhg‐csf adc based combination therapie anti-cancer drugs peptides oral delivery strategies adc for cancer phn obesity car-t cell pd-1 inhibitors multiple myeloma bispecific adcs her family antibody-drug conjugate (adc) nectin-4 delivery system isacs apdc aptamer-drug conjugate ovarian cancer her2 adcs adc payloads maytansinoids multiple myeloma (mm) bcma/cd3 influenza virus vaccine bystander effects adc payload covalent protacs arc antibody–sirna conjugates adc therapies sirna drugs her2-positive gastric cancer hydrogel bioink bioink multifunctional peptides oligonucleotide therapeutics syfovre glp-1r agonists adc-based combination therapy curcumin tetrahydrocurcumin antiobesity alzheimer disease dpp4 inhibitors antidiabetic drugs gene therapies zimura nasal cavity nasal spray vaccines rsvpref3 oa intravitreal pegcetacoplan srp-9001 non-small cell lung cancer immunotherapies targeted drug therapies sotyktu mounjaro opdualag small molecule drugs targeted drug therapy antibody-based therapies heterogeneous tumors dual payloads pegylated liposomes delivery strategies cas9 system mrna therapeutics targeted therapies lipid based nanoparticles nanotechnology mmaf mmae antibody–drug conjugate met ceacam5 her3 aspirin aps5 alkaline chemiluminescence immunoassay peg hydrogels drug development 3d bioprinted cancer models camptothecin floate-protac cliptacs photac biomedical applications bioorthogonal chemistry rnai aso antisense oligonucleotide rna therapies egfr-directed adc target the nobel prize tissue adhesives medical devices peg biomaterials car-t gene therapy solid tumor pharmaceuticals large scale chemicals polydispersed pegs monodispersed pegs biopharma peg multi-arm peg derivatives targeted degradation glp‐1 receptor agonists antibody conjugates multispecific antibodies arcs t-dm1 protac linkers acute lymphoblastic leukemia glp-1 receptors weight loss therapies peptide-drug conjugates icis) immune checkpoint inhibitors pd-l1 ribotacs heterobifunctional molecules trastuzumab deruxtecan bispecific attenuated vaccines dato-dxd heart failure peptide therapeutics multiple myeloma therapies protac degraders exosomes dac antibody targets targeted protein degrader small-molecule drugs hypoglycemic agents oral peptide therapeutics protein-polymer conjugates prodrug 3d printing blood-brain barrier nucleic acid drugs aoc rdc anti-diabetic drugs mrna drug delivery anticancer btk pdl-1 herpes zoster shingles mrna therapy adc linkers trop2 adc her2 adc orlistat anti-obesity drugs enjaymo vabysmo cibinqo quviviq ensitrelvir molnupiravir oligonucleotide drugs trop2-directed adcs polymer nanoparticles mrna covid-19 vaccines mrna vaccine delivery immune stimulating antibody conjugate peptide-drug conjugate lnp-mrna vaccines nanovaccines polydispersed peg linkers monodispersed peg linkers a pill for covid-19 malaria vaccine ai for protein folding covid-19 variant tracking ritonavir nirmatrelvir oral antiviral drug anti-diabetic intermediates arbidol influenza drugs dolutegravir intermediates antiretroviral drug pramipexole intermediates dopamine levodopa parkinson's disease pulp regeneration medical dressing tezspire rybrevant pepaxto lumakras leqvio cabenuva aduhelm teliso-v telisotuzumab vedotin breakthrough therapy designation c-met adc adagrasib cilta-cel mavacamten vutrisiran bardoxolone deucravacitinib gantenerumab protein degradation technology proteolysis-targeting chimeras aoms anti-obesity medications small molecule inhibitors alzheimer car t-cell therapy gs-ca1 aids candidate drug application pegylated interferon polycythemia vera ropeginterferon alfa-2b-njft besremi omicron dpp4 inhibitor sitagliptin long acting drugs anti cancer drugs low carbohydrate diet muc sacituzumab govitecan-hziy long-acting protein mrna delivery antibody conjugate drug pegylated drugs anti gout drugs peg uricase il-2 receptors peg-il-2 peg-interleukin-2 crispr gene editing mrna pipeline dna vaccines antibody therapy aids vaccine colorectal cancer peptide drug delta variant glp1 glucagon-like peptide 1 dmmr solid tumors pd-1 antibody targeted therapy drugs hepatitis b vaccine sars-cov-2 vaccine xarelto biktarvy opdivo stelara eylea imbruvica eliquis revlimid humira ebola vaccine hpv vaccine conjugate vaccine recombinant dna vaccine whooping cough vaccine fever vaccine tuberculosis vaccine live attenuated vaccine sarcoma carcinoma benign tumor tumor quadrivalent seasonal influenza vaccine mrna-1010 ceacam liv-1 folate receptor alpha butyric acid valeric acid scfa short chain fatty acids live cells monoclonal antibodies (mabs) peptides and proteins nucleic acids small molecules anti-cancer novel targeted therapy smdcs small molecule-drug conjugates therapeutics pegylated lipids weight-loss drug monodisperse peg car-t therapies innovative drugs sars-cov-2 enzalutamide mrna-based cancer vaccines pegylated conjugates peptide bonds entécavir nucleoside analogs wound dressing tissue engineering biomedical fields hydrogel nanomedicines lifestyle changes weight-loss drugs pharmaceutical intermediates liver cancer chronic hbv infection pd-1 inhibitor ezh2 inhibitor first cd19-targeted adc excipients antibody-conjugated drug pharmaceutical companies oncology series b financing candidate drug brilacidin lifestyle genetic risk gastric cancer car-t clofazimine genetic testing genetic mutations weight management piroctone olamine market forecast therapies ac-peg-ac bio-ink materials tumors normal cells application technology ingredients covid 19 vaccine car-t therapy blood testing biomedicine advancements kras inhibitors linc01271 oncogenes cphi remdesivir combination therapy pancreatic tumors hypoxia-responsive nanoparticles pancreatic cancer antibody drug conjugate anti-cancer drug sorafenib bacterial infections lipid droplets pegylated bilirubin nanoparticle hepatitis c virus oxyphotodynamic therapy influenza antiviral drugs virus precision oncology peptide viruses glut1 inhibitor antiviral tamiflu clinical nanomaterials peg dspe mersana therapeutics xmt-1536 t2dm patients lung cancer oligonucleotides therapeutic linker innovative barrier brain blood nano drugs vitrakvi degradation sirna drug dexamethasone boronic esters boronic acids alkyne azide injections paclitaxel palbociclib short chain dyes dbco gs-441524 antihypertensive therapy proteins targeted nano preparation quantum dots dspe-peg azithromycin hydroxychloroquine single-cell encapsulation dbco-peg antibiotic drugs bacterial viral molecule approval illnesses challange intermediate api inhibitors cdk4/6 tumor cell immune system biopharmaceutical biochempeg applications surface modification medicine health medical
Mehr anzeigen